Common drugs for type 2 diabetes and obesity do not increase the risk of breast cancer
WASHINGTON – Commonly used medications for type 2 diabetes and obesity called glucagon as peptide-1 receptor agonists (GLP-1 RAs), are not associated with an increased risk of breast cancer, …
